Daniel Billen - Net Worth and Insider Trading
Daniel Billen Net Worth
The estimated net worth of Daniel Billen is at least $234,133 dollars as of 2024-11-10. Daniel Billen is the Director of Aurinia Pharmaceuticals Inc and owns about 28,141 shares of Aurinia Pharmaceuticals Inc (AUPH) stock worth over $234,133. Details can be seen in Daniel Billen's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Daniel Billen has not made any transactions after 2024-05-21 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Daniel Billen
Daniel Billen Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Daniel Billen owns 1 companies in total, including Aurinia Pharmaceuticals Inc (AUPH) .
Click here to see the complete history of Daniel Billen’s form 4 insider trades.
Insider Ownership Summary of Daniel Billen
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| AUPH | Aurinia Pharmaceuticals Inc | 2024-05-21 | director |
Daniel Billen Latest Holdings Summary
Daniel Billen currently owns a total of 1 stock. Daniel Billen owns 28,141 shares of Aurinia Pharmaceuticals Inc (AUPH) as of May 21, 2024, with a value of $234,133.
Latest Holdings of Daniel Billen
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| AUPH | Aurinia Pharmaceuticals Inc | 2024-05-21 | 28,141 | 8.32 | 234,133 |
Holding Weightings of Daniel Billen
Daniel Billen Form 4 Trading Tracker
According to the SEC Form 4 filings, Daniel Billen has made a total of 2 transactions in Aurinia Pharmaceuticals Inc (AUPH) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Aurinia Pharmaceuticals Inc is the sale of 5,252 shares on May 21, 2024, which brought Daniel Billen around $30,147.
Insider Trading History of Daniel Billen
- 1
Daniel Billen Trading Performance
Daniel Billen Ownership Network
Ownership Network List of Daniel Billen
Ownership Network Relation of Daniel Billen
Daniel Billen Owned Company Details
What does Aurinia Pharmaceuticals Inc do?
Who are the key executives at Aurinia Pharmaceuticals Inc?
Daniel Billen is the director of Aurinia Pharmaceuticals Inc. Other key executives at Aurinia Pharmaceuticals Inc include Chief Commercial Officer Scott Michael Habig , director & Chief Executive Officer Peter Greenleaf , and Chief Financial Officer Joseph M Miller .
Aurinia Pharmaceuticals Inc (AUPH) Insider Trades Summary
Over the past 18 months, Daniel Billen made 2 insider transaction in Aurinia Pharmaceuticals Inc (AUPH) with a net sale of 9,902. Other recent insider transactions involving Aurinia Pharmaceuticals Inc (AUPH) include a net sale of 51,893 shares made by Scott Michael Habig , a net sale of 30,076 shares made by Volker Knappertz , and a net sale of 13,679 shares made by Jayne David R.w. .
In summary, during the past 3 months, insiders sold 0 shares of Aurinia Pharmaceuticals Inc (AUPH) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 387,417 shares of Aurinia Pharmaceuticals Inc (AUPH) were sold and 0 shares were bought by its insiders, resulting in a net sale of 387,417 shares.
Aurinia Pharmaceuticals Inc (AUPH)'s detailed insider trading history can be found in Insider Trading Tracker table.
Aurinia Pharmaceuticals Inc Insider Transactions
Daniel Billen Mailing Address
Above is the net worth, insider trading, and ownership report for Daniel Billen. You might contact Daniel Billen via mailing address: #1203-4464 Markham Street, Victoria A1 V8z 7x8.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
